Revision Eye Care, Llc | |
3341 8th St S, Wisconsin Rapids, WI 54494-6566 | |
(715) 423-5353 | |
(715) 423-6525 |
Full Name | Revision Eye Care, Llc |
---|---|
Type | Facility |
Speciality | Optometrist |
Location | 3341 8th St S, Wisconsin Rapids, Wisconsin |
Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1427563063 | NPI | - | NPPES |
100078371 | Medicaid | WI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | (* (Not Available)) | Primary |
Provider Name | Michael J Downs |
---|---|
Provider Type | Practitioner - Optometry |
Provider Identifiers | NPI Number: 1508901067 PECOS PAC ID: 2365575651 Enrollment ID: I20100806000831 |
News Archive
Aubrey Inc., an advanced wound care company, announced it has received clearance from the US Food and Drug Administration (FDA) to market the AWBAT Plus product line in the United States.
In patients with atrial fibrillation, delayed enhancement magnetic resonance imaging (DE-MRI) performed before ablative treatment can stage the degree of damaged heart tissue (atrial fibrosis) and help predict whether treatment will be successful or not, according to results of Delayed Enhancement - MRI determinant of successful Catheter Ablation of Atrial Fibrillation (DECAAF) trial.
Scientists at The University of Nottingham have discovered a molecular mechanism which could bring about the development of new treatments for Multiple Sclerosis (MS) — a chronic inflammatory disease of the central nervous system.
Acetaminophen (Tylenol and generics) is one of the most commonly used over-the-counter drugs in the United States. While generally safe, acetaminophen is known to cause severe liver injury if taken in high doses. But likely due to genetics, even the recommended dose can induce serious liver damage in a significant number of people.
› Verified 4 days ago
Provider Name | Peter Richard Falk |
---|---|
Provider Type | Practitioner - Optometry |
Provider Identifiers | NPI Number: 1619315421 PECOS PAC ID: 5092020032 Enrollment ID: I20150819008391 |
News Archive
Aubrey Inc., an advanced wound care company, announced it has received clearance from the US Food and Drug Administration (FDA) to market the AWBAT Plus product line in the United States.
In patients with atrial fibrillation, delayed enhancement magnetic resonance imaging (DE-MRI) performed before ablative treatment can stage the degree of damaged heart tissue (atrial fibrosis) and help predict whether treatment will be successful or not, according to results of Delayed Enhancement - MRI determinant of successful Catheter Ablation of Atrial Fibrillation (DECAAF) trial.
Scientists at The University of Nottingham have discovered a molecular mechanism which could bring about the development of new treatments for Multiple Sclerosis (MS) — a chronic inflammatory disease of the central nervous system.
Acetaminophen (Tylenol and generics) is one of the most commonly used over-the-counter drugs in the United States. While generally safe, acetaminophen is known to cause severe liver injury if taken in high doses. But likely due to genetics, even the recommended dose can induce serious liver damage in a significant number of people.
› Verified 4 days ago
Provider Name | Anna Nicole Kneiert |
---|---|
Provider Type | Practitioner - Optometry |
Provider Identifiers | NPI Number: 1598445850 PECOS PAC ID: 3173987823 Enrollment ID: I20230913002121 |
News Archive
Aubrey Inc., an advanced wound care company, announced it has received clearance from the US Food and Drug Administration (FDA) to market the AWBAT Plus product line in the United States.
In patients with atrial fibrillation, delayed enhancement magnetic resonance imaging (DE-MRI) performed before ablative treatment can stage the degree of damaged heart tissue (atrial fibrosis) and help predict whether treatment will be successful or not, according to results of Delayed Enhancement - MRI determinant of successful Catheter Ablation of Atrial Fibrillation (DECAAF) trial.
Scientists at The University of Nottingham have discovered a molecular mechanism which could bring about the development of new treatments for Multiple Sclerosis (MS) — a chronic inflammatory disease of the central nervous system.
Acetaminophen (Tylenol and generics) is one of the most commonly used over-the-counter drugs in the United States. While generally safe, acetaminophen is known to cause severe liver injury if taken in high doses. But likely due to genetics, even the recommended dose can induce serious liver damage in a significant number of people.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Revision Eye Care, Llc 3341 8th St S, Wisconsin Rapids, WI 54494-6566 Ph: (715) 423-5353 | Revision Eye Care, Llc 3341 8th St S, Wisconsin Rapids, WI 54494-6566 Ph: (715) 423-5353 |
News Archive
Aubrey Inc., an advanced wound care company, announced it has received clearance from the US Food and Drug Administration (FDA) to market the AWBAT Plus product line in the United States.
In patients with atrial fibrillation, delayed enhancement magnetic resonance imaging (DE-MRI) performed before ablative treatment can stage the degree of damaged heart tissue (atrial fibrosis) and help predict whether treatment will be successful or not, according to results of Delayed Enhancement - MRI determinant of successful Catheter Ablation of Atrial Fibrillation (DECAAF) trial.
Scientists at The University of Nottingham have discovered a molecular mechanism which could bring about the development of new treatments for Multiple Sclerosis (MS) — a chronic inflammatory disease of the central nervous system.
Acetaminophen (Tylenol and generics) is one of the most commonly used over-the-counter drugs in the United States. While generally safe, acetaminophen is known to cause severe liver injury if taken in high doses. But likely due to genetics, even the recommended dose can induce serious liver damage in a significant number of people.
› Verified 4 days ago
Scott Francis Bruneau, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1100 E Riverview Expy, Wisconsin Rapids, WI 54494 Phone: 715-423-1340 Fax: 715-423-1444 | |
Benjamin Reed Clark, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1220 Parkwood Dr, Wisconsin Rapids, WI 54494 Phone: 715-421-2111 Fax: 715-421-2123 | |
Carol Ann Sheker Main, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1220 Parkwood Dr, Wisconsin Rapids, WI 54494 Phone: 715-421-2111 Fax: 715-421-2123 | |
Becker Vision Center S.c. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2411 3rd St S, Wisconsin Rapids, WI 54494 Phone: 715-424-3937 Fax: 715-423-3330 | |
Parkwood Eyecare Associates, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1220 Parkwood Dr, Wisconsin Rapids, WI 54494 Phone: 715-421-2111 Fax: 715-421-2123 | |
Dr. Michael Desmond Main, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1220 Parkwood Dr, Wisconsin Rapids, WI 54494 Phone: 715-421-2111 Fax: 715-421-2123 | |
Soren A. Nywall, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1220 Parkwood Drive, Wisconsin Rapids, WI 54494 Phone: 715-421-2111 Fax: 715-421-2123 |